Article Text
Case report
Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
Abstract
Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.
- asthma
- drugs: respiratory system
- vasculitis
- respiratory system